推官网,引流量

直推官网引流,大量子站导流 效果持久显著

批量建站,提收录

形成站群推广模式 让搜索引擎大量收录!

提权重,树权威

实现权重提升 树立行业权威

部署快,自主可控

免费下载

省成本,提效率

多分站齐推广,性价比高 批量数据分析,帮助及时调整优化

关于OD
关于OD
特朗普访华,施展欧盟很愚蠢! 特朗普访华很得胜,但目下欧盟又尬在那了,因为他们还
关于OD
中新经纬5月18日电(董湘依)跟着好意思元体系里面实体经济的失衡,东说念主民币外
关于OD
开元棋牌官方网站入口 直播吧5月15日讯中超第12轮,北京国安主场4-2驯顺青岛
日前,国乒队员牛冠凯在酬酢平台告示喜信,晒出共创视频,与竹马之交的退役畅通员段冬
全球知谈,手机圈这两年的竞争还是到了尖锐化的进度,各家子品牌和性能线齐在拚命堆电
凡是稍稍可爱外出游玩的东说念主,齐不得不感喟我们国度的气候有多耐看。从东北漫天飞

OD资讯

ODZIXUN

OD资讯

查看更多
  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
acinetobacter pneumonia 相关文献:
How should we treat acinetobacter pneumonia?
Amaya-Villar R, Garnacho-Montero J.
Curr Opin Crit Care. 2019 Oct;25(5):465-472. doi: 10.1097/MCC.0000000000000649.
PMID:31335380
Nosocomial Acinetobacter pneumonia.
Luna CM, Aruj PK.
Respirology. 2007 Nov;12(6):787-91. doi: 10.1111/j.1440-1843.2007.01147.x.
PMID:17986104
Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy.
Vazquez Guillamet C, Kollef MH.
Clin Infect Dis. 2018 Oct 15;67(9):1455-1462. doi: 10.1093/cid/ciy375.
PMID:29741597
Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: A randomized controlled trial.
Ungthammakhun C, Vasikasin V, Simsiriporn W, Juntanawiwat P, Changpradub D.
Int J Infect Dis. 2024 Dec;149:107267. doi: 10.1016/j.ijid.2024.107267. Epub 2024 Oct 16.
PMID:39423948
Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Franzone JP, Mackow NA, van Duin D.
Curr Opin Infect Dis. 2024 Apr 1;37(2):137-143. doi: 10.1097/QCO.0000000000001001. Epub 2024 Jan 3.
PMID:38179988
Sulbactam-durlobactam for Acinetobacter pneumonia.
Mushtaq A, Anand Raman A.
Lancet Infect Dis. 2023 Aug;23(8):e283. doi: 10.1016/S1473-3099(23)00450-4.
PMID:37516133
Acinetobacter pneumonia: a review.
Hartzell JD, Kim AS, Kortepeter MG, Moran KA.
MedGenMed. 2007 Jul 5;9(3):4.
PMID:18092011
Sulbactam/durlobactam (Xacduro) for Acinetobacter pneumonia.
[No authors listed]
Med Lett Drugs Ther. 2023 Nov 27;65(1690):189-190. doi: 10.58347/tml.2023.1690c.
PMID:37983119
Current and novel therapies for management of Acinetobacter baumannii-associated pneumonia.
Shein AMS, Hongsing P, Smith OK, Phattharapornjaroen P, Miyanaga K, Cui L, Ishikawa H, Amarasiri M, Monk PN, Kicic A, Chatsuwan T, Pletzer D, Higgins PG, Abe S, Wannigama DL.
Crit Rev Microbiol. 2025 May;51(3):441-462. doi: 10.1080/1040841X.2024.2369948. Epub 2024 Jul 1.
PMID:38949254
Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?
Jean SS, Liu CY, Huang TY, Lai CC, Liu IM, Hsieh PC, Hsueh PR.
Expert Rev Anti Infect Ther. 2024 Dec;22(12):1171-1187. doi: 10.1080/14787210.2024.2412637. Epub 2024 Oct 9.
PMID:39381911
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3